In vitro studies have confirmed that the overexpression of MDM2 confers a more aggressive phenotype to breast cancer cell lines, including higher levels of cell motility and invasion, in addition to inducing the expression and activity of MMP9. The gene discussed is MMP9; the disease is breast carcinoma.